Form 4: Natera President Sells Shares
Insider Transaction (Form 4)
Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS of Natera, Inc., sold 3,000 shares of common stock on October 1, 2026.
Summary
- Open-market sale: disposed of 200 Common Stock at $411.62 ($82,324) on October 1, 2026; holds 109,714 after (Direct).
- Open-market sale: disposed of 954 Common Stock at $413.11 ($394,104) on October 1, 2026; holds 108,760 after (Direct).
- Open-market sale: disposed of 1,846 Common Stock at $415.07 ($766,218) on October 1, 2026; holds 106,914 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $1,242,645 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Solomon Moshkevich — Officer (PRESIDENT, CLINICALDIAGNOSTICS)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Open-market sale | Common Stock | 200 | $412 | $82.3K | 109,714 |
| 2026-10-01 | Open-market sale | Common Stock | 954 | $413 | $394.1K | 108,760 |
| 2026-10-01 | Open-market sale | Common Stock | 1,846 | $415 | $766.2K | 106,914 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Open-market sale (200 shares) |
| 2026-10-01 | Open-market sale (954 shares) |
| 2026-10-01 | Open-market sale (1,846 shares) |
Keywords
insider transaction, Form 4, NTRA, Natera, Inc., bearish, Solomon Moshkevich
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.